Epicrispr, a clinical-stage company pioneering gene-modulating therapies, today reported early clinical data from its ongoing ...

The movement of waves, patterns that carry sound, light or heat, through materials has been widely studied by physicists, as ...

The Phase 1b trial consisted of 24 patients with Parkinson’s disease, who received twice-weekly dosing of either HER-096 or placebo over a four-week period. The trial’s exploratory biomarker program ...

Phase 1 results confirm investigational drug-candidate G1090N has a favorable safety and tolerability profile, supporting further clinical evaluationCompelling anti-inflammatory activity of G1090N was ...

Bicara Therapeutics (NASDAQ:BCAX) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline its ...

Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...

Researchers in the Republic of Korea are pushing smart-window design beyond glass. Professor Sung Ho Song at Kongju National ...

CAIRO, Jan 1 (MENA) – Prime Minister Mostafa Madbouly reiterated on Thursday his keenness to conduct regular follow-up on the latest developments in the implementation status of the first phase ...

Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...

Avi Loeb's new study of 3I/ATLAS reveals a 7.1-hour rotation and a bizarre solar alignment, raising questions about the ...

Floquet control uses time-periodic drives to engineer quantum systems, creating dynamic changes in material properties ...

BHPian BlackBeard recently shared this with other enthusiasts:Hello folks. Since many enthusiasts here are keen on knowing ...